Abstract
The rate of suicide, which is the fourth leading cause of death in Korea, has been increasing rapidly. Thus, the development of appropriate crisis intervention and treatment approaches is important for efforts to prevent suicide. In the context of crisis intervention, interviews with persons at risk of suicidal behavior should be characterized by the following three elements: empathic communication (active listening), the evaluation of suicidal ideation and risk factors, and the enhancement of protective factors against suicide. The intensity of suicidal thoughts, thoughts of suicide methods, intent to act on suicidal thoughts, and specific suicide plans should be evaluated in detail. Risk factors associated with suicide include being male, older, or divorced; having a physical illness or a recent discharge from a psychiatric hospital; experiences of hopelessness or aggression; impulsivity; and easy access to a method of suicide. Any history of previous suicide attempts should be identified in all persons at risk for suicide because such a history is an important clinical indicator of both additional attempts and completed suicides. More than 90% of all suicides are attributable to an emotional or psychiatric illness such as depressive disorder, bipolar disorder, alcohol-use disorder, or schizophrenia. Therefore, immediate and appropriate psychiatric treatment for psychiatric illnesses related to suicide risk is essential. Hospitalization in a closed psychiatric ward can help to prevent suicide among those presenting with a high and immediate risk for suicide. In conclusion, suicide and attempted suicide can be prevented by adequate treatments such as antidepressants, lithium, clozapine, and cognitive-behavioral therapy.
Acknowledgement
This research was supported by a grant of the Korea Health 21 R&D, Ministry of Health and Welfare, Republic of Korea (A102065).
References
1. Korea National Statistical Office. 2010 Annual report on the cause of death statistics. 2011. Daejeon: Korea National Statistical Office.
2. Wasserman D, Rihmer Z, Rujescu D, Sarchiapone M, Sokolowski M, Titelman D, Zalsman G, Zemishlany Z, Carli V. The European Psychiatric Association (EPA) guidance on suicide treatment and prevention. Eur Psychiatry. 2012. 27:129–141.
3. Mishara BL, Chagnon F, Daigle M, Balan B, Raymond S, Marcoux I, Bardon C, Campbell JK, Berman A. Which helper behaviors and intervention styles are related to better short-term outcomes in telephone crisis intervention? Results from a Silent Monitoring Study of Calls to the U.S. 1-800-SUICIDE Network. Suicide Life Threat Behav. 2007. 37:308–321.
4. Dervic K, Oquendo MA, Grunebaum MF, Ellis S, Burke AK, Mann JJ. Religious affiliation and suicide attempt. Am J Psychiatry. 2004. 161:2303–2308.
5. Dervic K, Grunebaum MF, Burke AK, Mann JJ, Oquendo MA. Protective factors against suicidal behavior in depressed adults reporting childhood abuse. J Nerv Ment Dis. 2006. 194:971–974.
6. Dervic K, Carballo JJ, Baca-Garcia E, Galfalvy HC, Mann JJ, Brent DA, Oquendo MA. Moral or religious objections to suicide may protect against suicidal behavior in bipolar disorder. J Clin Psychiatry. 2011. 72:1390–1396.
7. Kessler RC, Berglund P, Borges G, Nock M, Wang PS. Trends in suicide ideation, plans, gestures, and attempts in the United States, 1990-1992 to 2001-2003. JAMA. 2005. 293:2487–2495.
8. Angst F, Stassen HH, Clayton PJ, Angst J. Mortality of patients with mood disorders: follow-up over 34-38 years. J Affect Disord. 2002. 68:167–181.
9. Carter TD, Mundo E, Parikh SV, Kennedy JL. Early age at onset as a risk factor for poor outcome of bipolar disorder. J Psychiatr Res. 2003. 37:297–303.
10. Isometsa ET. Psychological autopsy studies: a review. Eur Psychiatry. 2001. 16:379–385.
11. Kim SW, Stewart R, Kim JM, Shin IS, Yoon JS, Jung SW, Lee MS, Yim HW, Jun TY. Relationship between a history of a suicide attempt and treatment outcomes in patients with depression. J Clin Psychopharmacol. 2011. 31:449–456.
12. Vaiva G, Vaiva G, Ducrocq F, Meyer P, Mathieu D, Philippe A, Libersa C, Goudemand M. Effect of telephone contact on further suicide attempts in patients discharged from an emergency department: randomised controlled study. BMJ. 2006. 332:1241–1245.
13. Gehin A, Kabuth B, Pichene C, Vidailhet C. Ten year follow-up study of 65 suicidal adolescents. J Can Acad Child Adolesc Psychiatry. 2009. 18:117–125.
14. De Leo D, Padoani W, Lonnqvist J, Kerkhof AJ, Bille-Brahe U, Michel K, Salander-Renberg E, Schmidtke A, Wasserman D, Caon F, Scocco P. Repetition of suicidal behaviour in elderly Europeans: a prospective longitudinal study. J Affect Disord. 2002. 72:291–295.
15. Sinclair JM, Harriss L, Baldwin DS, King EA. Suicide in depressive disorders: a retrospective case-control study of 127 suicides. J Affect Disord. 2005. 87:107–113.
16. Jung WY, Park JM, Kang CJ, Lee BD, Lee YM. Clinical characteristics of completed versus non-completed suicide and re-attempt rates in 2-4 years. J Korean Neuropsychiatr Assoc. 2009. 48:488–495.
17. Kim SW, Kim SY, Kim JM, Suh TW, Shin IS, Kim SJ, Na GW, Kim SH, Yoon JS. A survey on attitudes toward suicide and suicidal behavior in Korea. J Korean Soc Biol Ther Psychiatry. 2008. 14:43–48.
18. Kim SW, Kim SY, Yang SJ, Kim JM, Shin IS, Jeong S, Yoo JA, Bae KY, Yoon JS. Psychosocial correlates of suicidal ideation in middle-school students. J Korean Neuropsychiatr Assoc. 2010. 49:604–610.
19. Kim SW, Bae KY, Kim JM, Kim SY, Yoo JA, Yang SJ, Shin IS, Park JH, Kim SH, Yoon JS. Psychosocial correlates of attempted suicide and attitudes toward suicide. J Korean Neuropsychiatr Assoc. 2010. 49:367–373.
20. Roy A. Distal risk factors for suicidal behavior in alcoholics: replications and new findings. J Affect Disord. 2003. 77:267–271.
21. Kolves K, Varnik A, Tooding LM, Wasserman D. The role of alcohol in suicide: a case-control psychological autopsy study. Psychol Med. 2006. 36:923–930.
23. Nakaya N, Kikuchi N, Shimazu T, Ohmori K, Kakizaki M, Sone T, Awata S, Kuriyama S, Tsuji I. Alcohol consumption and suicide mortality among Japanese men: the Ohsaki Study. Alcohol. 2007. 41:503–510.
24. Moller HJ. Evidence for beneficial effects of antidepressants on suicidality in depressive patients: a systematic review. Eur Arch Psychiatry Clin Neurosci. 2006. 256:329–343.
25. Rihmer Z, Akiskal H. Do antidepressants t(h)reat(en) depressives? Toward a clinically judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries. J Affect Disord. 2006. 94:3–13.
26. Jick H, Kaye JA, Jick SS. Antidepressants and the risk of suicidal behaviors. JAMA. 2004. 292:338–343.
27. Nivoli AM, Colom F, Murru A, Pacchiarotti I, Castro-Loli P, González-Pinto A, Fountoulakis KN, Vieta E. New treatment guidelines for acute bipolar depression: a systematic review. J Affect Disord. 2011. 129:14–26.
28. Akiskal HS, Benazzi F. Psychopathologic correlates of suicidal ideation in major depressive outpatients: is it all due to unrecognized (bipolar) depressive mixed states? Psychopathology. 2005. 38:273–380.
29. Cipriani A, Pretty H, Hawton K, Geddes JR. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry. 2005. 162:1805–1819.
30. Guzzetta F, Tondo L, Centorrino F, Baldessarini RJ. Lithium treatment reduces suicide risk in recurrent major depressive disorder. J Clin Psychiatry. 2007. 68:380–383.
31. Yerevanian BI, Koek RJ, Mintz J. Bipolar pharmacotherapy and suicidal behavior. Part I. Lithium, divalproex and carbamazepine. J Affect Disord. 2007. 103:5–11.
32. Lee KM, Kim SW, Yoon JS, Hong CH, Yeum SH, Sea YH, Bae A. The relationship between theory of mind and suicide attempts in patients with schizophrenia. Korean J Schizophr Res. 2011. 14:131–139.
33. Kim SW, Kim SJ, Mun JW, Bae KY, Kim JM, Kim SY, Yang SJ, Shin IS, Yoon JS. Psychosocial factors contributing to suicidal ideation in hospitalized schizophrenia patients in Korea. Psychiatry Investig. 2010. 7:79–85.
34. Meltzer HY, Alphs L, Green AI, Altamura AC, Anand R, Bertoldi A, Bourgeois M, Chouinard G, Islam MZ, Kane J, Krishnan R, Lindenmayer JP, Potkin S. International Suicide Prevention Trial Study Group. Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry. 2003. 60:82–91.